Rankings
▼
Calendar
ANIK Q1 2018 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ANIK
Anika Therapeutics, Inc.
$208M
Q1 2018 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$21M
-9.1% YoY
Gross Profit
$13M
63.1% margin
Operating Income
-$8M
-36.8% margin
Net Income
-$7M
-31.4% margin
EPS (Diluted)
$-0.46
QoQ Revenue Growth
-27.6%
Cash Flow
Operating Cash Flow
$10M
Free Cash Flow
$7M
Stock-Based Comp.
$8M
Balance Sheet
Total Assets
$284M
Total Liabilities
$21M
Stockholders' Equity
$264M
Cash & Equivalents
$142M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$21M
$23M
-9.1%
Gross Profit
$13M
$17M
-22.4%
Operating Income
-$8M
$8M
-197.8%
Net Income
-$7M
$5M
-221.7%
Revenue Segments
Product
$21M
49%
Orthobiologics
$19M
45%
Surgical
$1M
3%
Manufactured Product, Other
$1M
2%
Geographic Segments
UNITED STATES
$17M
88%
Europe
$2M
12%
← FY 2018
All Quarters
Q2 2018 →